Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab

Mult Scler Relat Disord. 2020 Sep:44:102314. doi: 10.1016/j.msard.2020.102314. Epub 2020 Jun 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alemtuzumab / administration & dosage
  • Alemtuzumab / therapeutic use*
  • COVID-19 / complications
  • COVID-19 / immunology*
  • Humans
  • Immunologic Factors / administration & dosage
  • Immunologic Factors / therapeutic use*
  • Lymphocyte Depletion*
  • Male
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology*
  • T-Lymphocyte Subsets / drug effects*
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Alemtuzumab